INTERNATIONAL PATENT: GENENTECH, INC., BIONTECH SE FILES APPLICATION FOR "METHODS OF TREATING UROTHELIAL CARCINOMA WITH A PD-1 AXIS BINDING ANTAGONIST AND AN RNA VACCINE"

GENEVA, July 30 -- GENENTECH, INC. (1 DNA WaySouth San Francisco, California 94080-4990), BIONTECH SE (An Der Goldgrube 1255131 Mainz) filed a patent application (PCT/US2025/011687) for "METHODS OF TREATING UROTHELIAL CARCINOMA WITH A PD-1 AXIS BINDING ANTAGONIST AND AN RNA VACCINE" on Jan 15, 2025. With publication no. WO/2025/155607, the details related to the patent application was published on Jul 24, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): YADAV, Mahesh (c/o Genentech, Inc.1 DNA WaySouth San Francisco, California 94080-4990), CARTER, Corey Allan (c/o Genentech, Inc.1 DNA WaySout...